Skip to main content

Prenatal environmental risk factors for autism spectrum disorder

Emerging research explores whether maternal use of SSRIs, antibiotics, and exposure to toxicants during pregnancy can be added to the list of established risk factors for ASD.

Read more

Editor's Choice

Protection against cirrhosis in people with MASLD and diabetes

GLP-1 receptor agonists may better protect against cirrhosis than DPP-4 inhibitors in people who have MASLD and type 2 diabetes but early treatment is important.

Weight-loss versus weight-neutral approaches to health

Weight-neutral health strategies have gained attention as a potential alternative to weight-loss strategies for adults with obesity. This review debates the effects of these two different approaches.

Novel antihyperglycemic agents and respiratory function

GLP-1 receptor agonists and SGLT2 inhibitors have established antidiabetic and cardiovascular benefits, but could they also improve respiratory function in people with type 2 diabetes?

MicroRNAs in diabetic macroangiopathy

Diabetic macroangiopathy is a leading cause of diabetes-related mortality. Could miRNAs improve the future outlook for diabetes patients? Learn about miRNA biogenesis and their functions in diabetic macroangiopathy to find out.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Prof. Samuel Seidu
Developed by: Adis
Listen now

Case Studies

Maternally inherited diabetes and deafness

  • Free for a limited time
  • Diabetes
  • Case Study

Genetic testing was needed to diagnose the mitochondrial disorder MIDD in a woman with diabetes, weight loss, and poor glycemic control. Glycated hemoglobin and pancreatic function improved after treatment with a DPP-4 inhibitor.

Stevens-Johnson syndrome/toxic epidermal necrolysis complicated with fulminant type 1 diabetes

A rare case of fulminant type 1 diabetes induced by SJS/TEN, which had developed in a patient taking carbamazepine and phenytoin. Glucose monitoring should be considered for patients with SJS/TEN.

Accidental use of dulaglutide into the third trimester

The GLP-1 receptor agonist dulaglutide was unintentionally used by a woman with type 2 diabetes until the third trimester of an unplanned and unrecognized pregnancy, but what was the outcome?

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more

Current Reviews

Characteristics of High-Intensity Interval Training Influence Anthropometrics, Glycemic Control, and Cardiorespiratory Fitness in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Exercise is a primary non-pharmacological intervention for managing body mass, reducing blood glucose levels, and enhancing insulin sensitivity in type 2 diabetes mellitus (T2DM) patients [ 1 ]. The recommended exercise regimen includes 150–300 min …

Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes

Diabetes is a growing pandemic and the impact of diabetes on health is projected to increase worldwide, mostly driven by increments in lower- and middle-income countries [ 1 ]. Individuals with diabetes are at an increased risk of cardiovascular …

Euglycemic Ketoacidosis Associated with SGLT-2 Inhibitors in Non-diabetic Patients—A Narrative Review

Euglycemic ketoacidosis is an acute, life-threatening emergency that is characterized by euglycemia, metabolic acidosis, and ketonemia. It is a well-recognized adverse event in diabetic patients taking sodium-glucose cotransporter-2 inhibitor …

Ziziphus jujuba (Jujube) in Metabolic Syndrome: From Traditional Medicine to Scientific Validation

Metabolic syndrome is a multidimensional disorder marked by a cluster of metabolic abnormalities such as central obesity, insulin resistance, dyslipidemia, and hypertension. This condition represents a significant global health concern due to its …

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu
Listen now

CME & eLearning

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Tweetorials | Vodcasts | Infographics (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

Further Reading

Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study

  • Open Access
  • Diabetes
  • Original Research

Acute myocardial infarction (AMI) is the leading cause of mortality globally [ 1 ], with the incidence of non-ST segment myocardial infarction (NSTEMI), in particular, increasing [ 2 ]. Diabetes mellitus is an important risk factor for NSTEMI, with …

Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers

Type 1 diabetes is a life-long chronic autoimmune disease with an annual incidence among young people (under 20 years) of around 130,000 worldwide [ 1 ]. Its development typically runs from seroconversion (stage 1) to hyperglycaemia (stage 2), to …

Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

Managing Inherited Metabolic Disorders (IMDs) at risk for hypoglycemia, such as Glycogen Storage Diseases (GSDs), Hereditary Fructose Metabolism Disorders (HFMDs) and Congenital Hyperinsulinism (CH), poses challenges in dietary treatments and …

Long-Term Effects of Transtheoretical Model-Based Lifestyle Intervention on Self-efficacy and Self-management in Patients with Type 2 Diabetes — Randomised Controlled Trial

Diabetes mellitus (DM) is one of the four most common chronic diseases worldwide. It currently affects around 61.4 million people in Europe, and the prognosis continues to rise [ 1 ]. A major problem is the numerous comorbidities and secondary …

Related topics